Auna (NYSE:AUNA) Given New $14.00 Price Target at JPMorgan Chase & Co.

Auna (NYSE:AUNA) had its price target reduced by JPMorgan Chase & Co. from $16.00 to $14.00 in a research note released on Tuesday, Benzinga reports. They currently have an overweight rating on the stock.

Separately, HSBC initiated coverage on Auna in a research note on Tuesday, April 23rd. They issued a buy rating and a $12.60 target price on the stock.

Auna Stock Up 3.2 %

Shares of AUNA stock opened at $7.75 on Tuesday. The firm has a 50 day simple moving average of $8.10. The company has a current ratio of 0.89, a quick ratio of 0.82 and a debt-to-equity ratio of 1.94. Auna has a 52-week low of $6.17 and a 52-week high of $10.85.

Auna (NYSE:AUNA) last posted its quarterly earnings results on Wednesday, May 22nd. The company reported $0.10 earnings per share for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.04). The firm had revenue of $286.43 million during the quarter, compared to the consensus estimate of $292.12 million. As a group, sell-side analysts expect that Auna will post 0.5 earnings per share for the current fiscal year.

Institutional Trading of Auna

A number of large investors have recently made changes to their positions in the company. Verde Servicos Internacionais S.A. bought a new position in Auna during the first quarter worth about $3,461,000. Capstone Investment Advisors LLC bought a new position in shares of Auna during the 1st quarter valued at about $1,410,000. Sandia Investment Management LP acquired a new position in shares of Auna in the 1st quarter valued at approximately $160,000. BTG Pactual Global Asset Management Ltd bought a new stake in Auna during the 1st quarter worth approximately $1,172,000. Finally, Jane Street Group LLC acquired a new stake in Auna during the 1st quarter worth approximately $6,899,000.

Auna Company Profile

Auna SA, a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.